Geneva, Switzerland, September 8, 2021 — STALICLA, a Swiss clinical-stage biotech company advancing precision medicine to patients with Autism Spectrum Disorders and other Neurodevelopmental Disorders, announced today that its CEO and Founder, Lynn Durham, will present at the THE NEUROLOGICAL DISEASES & MENTAL HEALTH DISORDERS CONFERENCE, on September 9, 2021.
Ms Durham’s presentation will take place virtually at 11:20 EPT / 17:20 CEST (Agenda: